Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism

Clinical Biochemistry

Volumn 40, Issue 9-10, 2007, Pages 710-717

  Baudhuin, Linnea M ^a   Highsmith, W Edward ^a   Skierka, Jennifer ^a   Holtegaard, Leonard ^a   Moore, Brenda E ^a   O'Kane, Dennis J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Capillary electrophoresis; Fragment analysis; Genotyping; Irinotecan; Sequencing; TATA box; UGT1A1

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A1;

ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DNA DETERMINATION; DNA SEQUENCE; FLUORESCENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AFRICAN AMERICANS; ALLELES; CAMPTOTHECIN; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TIME FACTORS;

EID: 34249727317     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.03.007     Document Type: Article

References (34)

1. Gong Q.H., Cho J.W., Huang T., et al. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11 (2001) 357-368
2. Miners J.O., McKinnon R.A., and Mackenzie P.I. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology 181-182 (2002) 453-456
3. Beutler E., Gelbart T., and Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8170-8174
4. Iolascon A., Faienza M.F., Centra M., Storelli S., Zelante L., and Savoia A. (TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome. Haematologica 84 (1999) 106-109
5. Raijmakers M.T., Jansen P.L., Steegers E.A., and Peters W.H. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J. Hepatol. 33 (2000) 348-351
6. Bosma P.J. Inherited disorders of bilirubin metabolism. J. Hepatol. 38 (2003) 107-117
7. Biondi M.L., Turri O., Dilillo D., Stival G., and Guagnellini E. Contribution of the TATA-box genotype (Gilbert syndrome) to serum bilirubin concentrations in the Italian population. Clin. Chem. 45 (1999) 897-898
8. Te Morsche R.H., Zusterzeel P.L., Raijmakers M.T., Roes E.M., Steegers E.A., and Peters W.H. Polymorphism in the promoter region of the bilirubin UDP-glucuronosyltransferase (Gilbert's syndrome) in healthy Dutch subjects. Hepatology 33 (2001) 765
9. Borlak J., Thum T., Landt O., Erb K., and Hermann R. Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects. Hepatology 32 (2000) 792-795
10. Ando Y., Chida M., Nakayama K., Saka H., and Kamataki T. The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics 8 (1998) 357-360
11. Balram C., Sabapathy K., Fei G., Khoo K.S., and Lee E.J. Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1*28 is a common allele in Indians. Pharmacogenetics 12 (2002) 81-83
12. Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J. 3 (2003) 136-158
13. Aono S., Adachi Y., Uyama E., et al. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 345 (1995) 958-959
14. Sugatani J., Yamakawa K., Yoshinari K., et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem. Biophys. Res. Commun. 292 (2002) 492-497
15. Maruo Y., Sato H., Bamba N., et al. Chemotherapy-induced unconjugated hyperbilirubinemia caused by a mutation of the bilirubin uridine-5′-diphosphate-glucuronosyltransferase gene. J. Pediatr. Hematol. Oncol. 23 (2001) 45-47
16. Ando Y., Saka H., Ando M., et al. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res. 60 (2000) 6921-6926
17. Ando Y., Ueoka H., Sugiyama T., Ichiki M., Shimokata K., and Hasegawa Y. Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan. Ther. Drug Monit. 24 (2002) 111-116
18. Iyer L., Das S., Janisch L., et al. UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J. 2 (2002) 43-47
19. Marsh S., and McLeod H.L. Pharmacogenetics of irinotecan toxicity. Pharmacogenomics 5 (2004) 835-843
20. U.S. Food and Drug Administration. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfivd/index.cfms?db=PMN&id=K051824.
21. von Ahsen N., Oellerich M., and Schutz E. DNA base bulge vs unmatched end formation in probe-based diagnostic insertion/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR. Clin. Chem. 46 (2000) 1939-1945
22. Saeki M., Saito Y., Jinno H., et al. Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing. Clin. Chem. 49 (2003) 1182-1185
23. Marziliano N., Pelo E., Minuti B., Passerini I., Torricelli F., and Da Prato L. Melting temperature assay for a UGT1A gene variant in Gilbert syndrome. Clin. Chem. 46 (2000) 423-425
24. Harraway J.R., and George P.M. Use of fully denaturing HPLC for UGT1A1 genotyping in Gilbert syndrome. Clin. Chem. 51 (2005) 2183-2185
25. Ostanek B., Furlan D., Mavec T., and Lukac-Bajalo J. UGT1A1(TA)(n) promoter polymorphism-a new case of a (TA)(8) allele in Caucasians. Blood Cells Mol. Diseases 38 (2007) 78-82
26. Arambula E., and Vaca G. Genotyping by "cold single-strand conformation polymorphism" of the UGT1A1 promoter polymorphism in Mexican mestizos. Blood Cells Mol. Diseases 28 (2002) 86-90
27. Pirulli D., Giordano M., Puzzer D., et al. Rapid method for detection of extra (TA) in the promoter of the bilirubin-UDP-glucuronosyl transferase 1 gene associated with Gilbert syndrome. Clin. Chem. 46 (2000) 129-131
28. Skarke C., Grosch S., Geisslinger G., and Lotsch J. Single-step identification of all length polymorphisms in the UGT1A1 gene promoter. Int. J. Clin. Pharmacol. Ther. 42 (2004) 133-138
29. Brownstein M.J., Carpten J.D., and Smith J.R. Modulation of non-templated nucleotide addition by Taq DNA polymerase: primer modifications that facilitate genotyping. Biotechniques 20 1004-6 (1996) 8-10
30. Akaba K., Kimura T., Sasaki A., et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem. Mol. Biol. Int. 46 (1998) 21-26
31. Seppen J., Steenken E., Lindhout D., Bosma P.J., and Elferink R.P. A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett. 390 (1996) 294-298
32. Kadakol A., Ghosh S.S., Sappal B.S., Sharma G., Chowdhury J.R., and Chowdhury N.R. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Human Mutat. 16 (2000) 297-306
33. Ciotti M., Chen F., Rubaltelli F.F., and Owens I.S. Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease. Biochim. Biophys. Acta 1407 (1998) 40-50
34. Han J.Y., Lim H.S., Shin E.S., et al. Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J. Clin. Oncol. 24 (2006) 2237-2244